Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO 140 Monotherapy in CCR5-tropic HIV-1
NCT02859961Phase 3Completed
- Sponsor
- CytoDyn Inc.
- Start
- Dec 2016
- Primary completion
- Sep 2020
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of leronlimab in human immunodeficiency virus type 1 infection (HIV-1), sponsored by CytoDyn Inc.. Started Dec 2016; status: completed.
02
Drugs
leronlimab
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02859961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02859961.